SUSAN LALLY: Open Payments
NPI 1861052979 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 17 payments from 9 companies in 2025. Trend: 2023 $1,221 · 2024 $885 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Lundbeck LLC | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, SPRAVATO, REXULTI, COBENFY, INGREZZA, CAPLYTA, HETLIOZ, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
